Bellevue Medtech & Services CA CHF

Reference Data

ISIN CH0269985385
Valor Number 26998538
Bloomberg Global ID
Fund Name Bellevue Medtech & Services CA CHF
Fund Provider Bellevue Asset Management AG Zürich, Switzerland
Phone: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Fund Provider Bellevue Asset Management AG
Representative in Switzerland
Distributor(s) Zürcher Kantonalbank
Zürich
Phone: +41 44 293 93 93
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Switzerland
Issuing Condition Special conditions apply to the issue of units
Redemption Condition Special conditions apply to the redemption of units
Investment Strategy *** n.a.
Peculiarities

Fund Prices

Current Price * 96.51 CHF 20.01.2026
Previous Price * 98.27 CHF 16.01.2026
52 Week High * 124.51 CHF 03.02.2025
52 Week Low * 90.04 CHF 06.08.2025
NAV * 96.51 CHF 20.01.2026
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 52,711,081
Unit/Share Assets *** 5,244,718
Trading Information SIX

Performance

YTD Performance -0.23% 31.12.2025
20.01.2026
1 month -0.79% 22.12.2025
20.01.2026
3 months -1.65% 20.10.2025
20.01.2026
6 months +6.07% 21.07.2025
20.01.2026
1 year -19.86% 21.01.2025
20.01.2026
2 years -10.28% 22.01.2024
20.01.2026
3 years -13.71% 20.01.2023
20.01.2026
5 years -10.96% 20.01.2021
20.01.2026

Tax Data

Equity Participation Rate in % 99.07
Share of Total Fund Assets in %
Real Estate Rate in % 0.00
ADDI
ADDI Date

Top 10 Holdings ***

UnitedHealth Group Inc 14.25%
Abbott Laboratories 10.88%
Intuitive Surgical Inc 10.03%
Boston Scientific Corp 7.86%
Stryker Corp 7.04%
Medtronic PLC 5.88%
McKesson Corp 4.92%
Essilorluxottica 4.79%
CVS Health Corp 4.41%
HCA Healthcare Inc 4.13%
Last data update 30.11.2025

Cost / Risk

TER 1.55%
TER date 30.09.2024
Performance Fee *** 10.00%
PTR
Max. Management Fee *** 1.80%
Ongoing Charges ***
SRRI ***
SRRI date *** 31.12.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)